Polyoxometalate-based heterojunction with NIR light-facilitated photocatalytic W6+/W5+ redox cycling for enhanced bacteria-infected wound healing

Lv, Mingzhu; Xu, Zhou; Yuan, Yong; Wang, Huan; Liu, Chenghui; Xu, Qiqi; Du, Guobo; Xie, Jiani; You, Yong; Xiao, Jiangwei; Jiang, Guohui

doi:10.1016/j.matdes.2023.111673

Cited by 6 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the high GSH content in the biofilm, GdP 5 W 30 @WS 2 can be used as a biofilm microenvironment‐triggered therapeutic for the treatment of biofilm‐infected diseases. [ 52 ] Since the heat can increase the catalytic reaction rate, further enhancing the therapeutic efficacy of CDT. Many chemodynamic agents with photothermal performance have been developed.…”

Section: Cdt‐based Combined Therapymentioning

confidence: 99%

Recent design strategies for boosting chemodynamic therapy of bacterial infections

Zhang,

Guo,

Liu

et al. 2023

Exploration

View full text Add to dashboard Cite

The emergence of drug‐resistant bacteria poses a significant threat to people's lives and health as bacterial infections continue to persist. Currently, antibiotic therapy remains the primary approach for tackling bacterial infections. However, the escalating rates of drug resistance coupled with the lag in the development of novel drugs have led to diminishing effectiveness of conventional treatments. Therefore, the development of nonantibiotic‐dependent therapeutic strategies has become imperative to impede the rise of bacterial resistance. The emergence of chemodynamic therapy (CDT) has opened up a new possibility due to the CDT can convert H2O2 into •OH via Fenton/Fenton‐like reaction for drug‐resistant bacterial treatment. However, the efficacy of CDT is limited by a variety of practical factors. To overcome this limitation, the sterilization efficiency of CDT can be enhanced by introducing the therapeutics with inherent antimicrobial capability. In addition, researchers have explored CDT‐based combined therapies to augment its antimicrobial effects and mitigate its potential toxic side effects toward normal tissues. This review examines the research progress of CDT in the antimicrobial field, explores various strategies to enhance CDT efficacy and presents the synergistic effects of CDT in combination with other modalities. And last, the current challenges faced by CDT and the future research directions are discussed.

show abstract

Section: Cdt‐based Combined Therapymentioning

confidence: 99%